Glaxosmithkline

Latest Articles

Axovant’s Vivek Ramaswamy Aims to Reinvent Dementia Treatment

Kaitlin Ugolik

Ben Thorpe Helps Keep Goldman’s Health M&A Franchise in Top Shape

David Rothnie

Blackstone Bids For GSK Drug Portfolio

Cazenove To Avoid EM Exposure

Daily Agenda: Oil Prices Finding Footing

Andrew Barber

Daily Agenda: The Week Ahead, February 2 – 6, 2015

Andrew Barber

Daily Agenda: The Week Ahead, July 27 – August 1, 2015

Andrew Barber

GlaxoSmithKline’s Andrew Witty: On a Mission

Neil Sen

GSK Eyes $2B Acquisitions In India

GSK Finalizes PE Firms For Assets Sale

GSK To Repurchase £2B Of Shares

Henderson Manager Favors Pharma

How Morgan Stanley Alumnus Michael Zaoui Made an M&A Comeback

David Rothnie

Meteor Introduces FTSE Structured Product

MIT’s Andrew Lo Touts Megafund to Tackle Cancer, Rare Diseases

Kaitlin Ugolik

PE Firms Eye Glaxosmithkline Portfolio

Tech Banker Ken Olisa Champions Good Corporate Governance

Jess Delaney

Thomas H Lee Partners In Race For GSK Unit

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-17 Login